Education
About Us
Working with TipRanks
Follow Us
Shanghai Heartcare Medical Technology Corp. Ltd. Class H (HK:6609)
:6609
RESEARCH TOOLSreports
Total Valuation
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has a market cap or net worth of HK$1.10B. The enterprise value is ―.
Market CapHK$1.10B
Enterprise Value―
Share Statistics
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has 31,565,804 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,565,804
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -10.11%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-10.11%
Return on Capital Employed (ROCE)-0.11
Revenue Per Employee675.42K
Profits Per Employee-273.29K
Employee Count344
Asset Turnover0.19
Inventory Turnover0.47
Valuation Ratios
The current PE Ratio of Shanghai Heartcare Medical Technology Corp. Ltd. Class H is -10.92. Shanghai Heartcare Medical Technology Corp. Ltd. Class H’s PEG ratio is -0.87.
PE Ratio-10.92
PS Ratio0.00
PB Ratio1.06
Price to Fair Value0.95
Price to FCF-64.58
Price to Operating Cash Flow-62.60
PEG Ratio-0.87
Income Statement
In the last 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H had revenue of 232.34M and earned -94.01M in profits. Earnings per share was -2.47.
Revenue232.34M
Gross Profit163.76M
Operating Income-126.87M
Pretax Income-102.92M
Net Income-94.01M
EBITDA-68.50M
Earnings Per Share (EPS)-2.47
Cash Flow
In the last 12 months, operating cash flow was -88.41M and capital expenditures -4.58M, giving a free cash flow of -92.98M billion.
Operating Cash Flow-88.41M
Free Cash Flow-92.98M
Free Cash Flow per Share-2.95
Dividends & Yields
Shanghai Heartcare Medical Technology Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change52.75%
50-Day Moving Average28.85
200-Day Moving Average22.42
Relative Strength Index (RSI)51.60
Average Volume (3m)11.05K
Important Dates
Shanghai Heartcare Medical Technology Corp. Ltd. Class H upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Shanghai Heartcare Medical Technology Corp. Ltd. Class H as a current ratio of 16.82, with Debt / Equity ratio of 3.38%
Current Ratio16.82
Quick Ratio14.37
Debt to Market Cap0.00
Net Debt to EBITDA8.55
Interest Coverage Ratio-58.79
Taxes
In the past 12 months, Shanghai Heartcare Medical Technology Corp. Ltd. Class H has paid -8.91M in taxes.
Income Tax-8.91M
Effective Tax Rate0.09
Enterprise Valuation
Shanghai Heartcare Medical Technology Corp. Ltd. Class H EV to EBITDA ratio is -6.43, with an EV/FCF ratio of -3.20.
EV to Sales1.90
EV to EBITDA-6.43
EV to Free Cash Flow-3.20
EV to Operating Cash Flow-4.98
Balance Sheet
Shanghai Heartcare Medical Technology Corp. Ltd. Class H has HK$721.14M in cash and marketable securities with ¥36.38M in debt, giving a net cash position of -HK$684.76M billion.
Cash & Marketable SecuritiesHK$721.14M
Total Debt¥36.38M
Net Cash-HK$684.76M
Net Cash Per Share-HK$21.69
Tangible Book Value Per ShareHK$27.00
Margins
Gross margin is 58.71%, with operating margin of -54.60%, and net profit margin of -40.46%.
Gross Margin58.71%
Operating Margin-54.60%
Pretax Margin-44.30%
Net Profit Margin-40.46%
EBITDA Margin-29.48%
EBIT Margin-43.37%
Analyst Forecast
The average price target for Shanghai Heartcare Medical Technology Corp. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast17.45%
EPS Growth Forecast85.71%